戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 maging, without other diet modification or a cathartic.
2 fore imaging, without diet modification or a cathartic.
3 resistant to bacterial metabolism and has no cathartic activity.
4  for colorectal cancer, especially when both cathartic and tagging agents are combined in the bowel p
5 ers were missed at CT colonography when both cathartic and tagging agents were combined in the bowel
6 experience discomfort and inconvenience with cathartic bowel preparation.
7  referred to as resin) in combination with a cathartic, but the effect of such therapy on serum potas
8 d patient comfort among the noncathartic and cathartic cohorts were compared with nonparametric analy
9                   All participants underwent cathartic preparation with stool tagging; electronic cle
10                           Background Limited cathartic preparations for CT colonography with fecal ta
11 he response of the jejunal mucosa to a known cathartic provides observations pertinent to the pathoph
12 aluates the effect of four single-dose resin-cathartic regimens and placebo on 5 different test days
13                                         Both cathartic regimens offered excellent colon cleansing, wi
14                                            A cathartic (sodium phosphate) and an emetic (ipecac) were
15 m vomitus and, occasionally, from saliva and cathartic stools.
16                    Because single-dose resin-cathartic therapy produces no or only trivial reductions
17 harmaceuticals only, as well as discouraging cathartic use with charcoal dosing.
18 itant administration of sorbitol, an osmotic cathartic used to prevent SPS-induced fecal impaction an
19     Since bowel preparation provided by both cathartics was comparable, magnesium citrate should be c